Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.
View Top Employees from Pear TherapeuticsWebsite | http://www.peartherapeutics.com |
Revenue | $29 million |
Funding | $234 million |
Employees | 202 (202 on RocketReach) |
Founded | 2013 |
Address | 200 State St, Boston, Massachusetts 02109, US |
Phone | (646) 932-2774 |
Technologies |
JavaScript,
HTML,
Twitter
+101 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Healthcare Software, Pharmaceuticals, Software Development & Design, Science and Engineering, Mobile Healthcare, Software, mHealth, Substance Use Disorder, Health Care, Neurogaming, Mobile, Digital Healthcare, Therapeutics, Opiate Dependence |
Web Rank | 2 Million |
Keywords | Pear Therapeutics, Pear Theruputics, Contingency Management Mobile App, Pear Therapeutics!, Pear Therapeutics T Pass |
Competitors | Akili, Big Health, Rapidops Inc., Virta Health, Welldoc |
SIC | SIC Code 73 Companies, SIC Code 737 Companies |
NAICS | NAICS Code 5112 Companies, NAICS Code 51 Companies, NAICS Code 511 Companies, NAICS Code 511210 Companies, NAICS Code 51121 Companies |
Looking for a particular Pear Therapeutics employee's phone or email?
The Pear Therapeutics annual revenue was $29 million in 2024.
Brian Prunier is the Vice President, Patient Services of Pear Therapeutics.
202 people are employed at Pear Therapeutics.
Pear Therapeutics is based in Boston, Massachusetts.
The NAICS codes for Pear Therapeutics are [5112, 51, 511, 511210, 51121].
The SIC codes for Pear Therapeutics are [73, 737].